APP and Alzheimer disease: In the transgenic amyloid precursor protein mouse model of Alzheimer’s disease, Aβ40, but not Aβ42, reproduced the cerebrovascular alterations and cognitive decline, pointing to a possible relationship between Aβ40 and microvascular injury in cognitive dysfunction31.